EE125 Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Immunization Using Monoclonal Antibodies (mAB) in United States Infants: An Analysis of In-Season and out-of-Season Birth Cohorts
https://www.valueinhealthjournal.com/article/S1098-3015(22)00576-9/fulltext
EPH72 Potential Adverse Effects of Passive Immunization Against Respiratory Syncytial Virus (RSV) in Low-Risk Infants in the United States
https://www.valueinhealthjournal.com/article/S1098-3015(22)01026-9/fulltext
Copyright © 2024 alitfarid - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.